SCHEMBL8089434

SCHEMBL8089434

O=C(Cl)[C@H]1CCC=C[C@H]1c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.39
AKR1C1 Q04828 1/20 0.39
HDAC4 P56524 2/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.36
SLC9A1 P19634 1/20 0.35
SIGMAR1 Q99720 3/20 0.35
HRH3 Q9Y5N1 5/20 0.34
NPSR1 Q6W5P4 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089436 1.00 AKR1C3 (0.39) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL7829311 1.00 AKR1C3 (0.39) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL7828959 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL7824679 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL8706518 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL8096848 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL8096658 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL8089417 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL8089414 0.86 AKR1C3 (0.44) AKR1C3AKR1C1HDAC4ALDH1A1HPGD
SCHEMBL7828978 0.79 SLC6A4 (0.49) MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166037-A Pyrrolidine and piperidine modulators of chemokine receptor activity MERCK & CO., INC. (US) 2000-12-26 US disclosed